We also systematically excluded patients with newly identified childhood liver diseases, such as autoimmune hepatitis, and those with a nonhepatic explanation of ALT > 500 U/L from the study cohort, which may inflate the numerator of cases with SAH-UE. The gene discussed is GPT; the disease is autoimmune hepatitis.